4//SEC Filing
Drygin Denis 4
Accession 0001209191-21-008156
CIK 0001505512other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:00 PM ET
Size
5.4 KB
Accession
0001209191-21-008156
Insider Transaction Report
Form 4
Drygin Denis
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-04+120,000→ 120,000 totalExercise: $1.59Exp: 2031-02-04→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The stock option commenced vesting on January 1, 2021 and will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001819692
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 5:00 PM ET
- Size
- 5.4 KB